[go: up one dir, main page]

WO2013046059A3 - Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose - Google Patents

Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose Download PDF

Info

Publication number
WO2013046059A3
WO2013046059A3 PCT/IB2012/002608 IB2012002608W WO2013046059A3 WO 2013046059 A3 WO2013046059 A3 WO 2013046059A3 IB 2012002608 W IB2012002608 W IB 2012002608W WO 2013046059 A3 WO2013046059 A3 WO 2013046059A3
Authority
WO
WIPO (PCT)
Prior art keywords
tamarind
trehalose
ocular disease
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2012/002608
Other languages
English (en)
Other versions
WO2013046059A2 (fr
Inventor
Robert C SYKORA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2013046059A2 publication Critical patent/WO2013046059A2/fr
Publication of WO2013046059A3 publication Critical patent/WO2013046059A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une préparation ophtalmique pour application topique sur l'œil, la préparation étant constituée, entre autres ingrédients, (a) de tamarin et (b) de tréhalose en des quantités suffisantes pour traiter une maladie oculaire caractérisée par une sécheresse oculaire, une inflammation superficielle de l'œil, ou une lésion superficielle de l'œil.
PCT/IB2012/002608 2011-09-27 2012-09-25 Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose Ceased WO2013046059A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161539582P 2011-09-27 2011-09-27
US61/539,582 2011-09-27

Publications (2)

Publication Number Publication Date
WO2013046059A2 WO2013046059A2 (fr) 2013-04-04
WO2013046059A3 true WO2013046059A3 (fr) 2013-07-11

Family

ID=47996547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/002608 Ceased WO2013046059A2 (fr) 2011-09-27 2012-09-25 Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose

Country Status (1)

Country Link
WO (1) WO2013046059A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9555054B2 (en) 2012-11-21 2017-01-31 University Of Louisville Research Foundation, Inc. Compositions and methods for reducing oxidative damage
WO2016130478A1 (fr) 2015-02-09 2016-08-18 University Of Louisville Research Foundation, Inc. Compositions ophtalmiques et procédés de réduction des dommages oxydatifs d'un cristallin oculaire
US10849918B2 (en) * 2015-07-13 2020-12-01 Tohoku Techno Arch Co., Ltd. Composition for optic nerve protection
CN114177280B (zh) * 2021-12-17 2025-08-19 上海卫康光学眼镜有限公司 一种含稳定性抗氧化酶的洗眼液及其制备方法
WO2024201425A1 (fr) * 2023-03-31 2024-10-03 Procyto Labs Pvt Ltd. Gel oculaire bloquant les allergènes sans conservateur

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911933A (en) * 1985-05-29 1990-03-27 Eye Research Institute Of Retina Foundation Non-toxic opthalmic preparations
EP0538313B1 (fr) * 1990-07-06 1999-04-07 Insite Vision, Inc. Suspensions ophtalmiques topiques
US6056950A (en) * 1996-02-05 2000-05-02 Farmigea S.P.A. Ophthalmic solutions viscosified with tamarind seed polysaccharide
US20070077278A1 (en) * 2003-11-10 2007-04-05 Yukiko Sugihara Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US20090118262A1 (en) * 2007-11-01 2009-05-07 Rohrs Brian R Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911933A (en) * 1985-05-29 1990-03-27 Eye Research Institute Of Retina Foundation Non-toxic opthalmic preparations
EP0538313B1 (fr) * 1990-07-06 1999-04-07 Insite Vision, Inc. Suspensions ophtalmiques topiques
US6056950A (en) * 1996-02-05 2000-05-02 Farmigea S.P.A. Ophthalmic solutions viscosified with tamarind seed polysaccharide
US20070077278A1 (en) * 2003-11-10 2007-04-05 Yukiko Sugihara Polysaccharide-containing composition and tear film stabilizing ophthalmic solution
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US20090118262A1 (en) * 2007-11-01 2009-05-07 Rohrs Brian R Non-Aqueous Water-Miscible Materials as Vehicles for Drug Delivery

Also Published As

Publication number Publication date
WO2013046059A2 (fr) 2013-04-04

Similar Documents

Publication Publication Date Title
WO2012103186A3 (fr) Composition androgène pour le traitement d'une affection ophtalmique
HK1258588A1 (zh) 用於治療眼科疾病的化合物和製劑
HK1198631A1 (en) Prevention and treatment of ocular conditions
IL260585B (en) Compositions and methods for treating retinal diseases
HK1211867A1 (en) Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
NZ704247A (en) Compositions and treatment for eye diseases and disorders
MY169328A (en) Compositions for the treatment of dry eye
WO2013180834A3 (fr) Compositions et procédés d'inhibition de masp-1 et/ou masp-3 pour le traitement l'hémoglobinurie paroxysmique nocturne
WO2012080497A3 (fr) Procédés de traitement et de prévention de maladies oculaires
WO2011151079A3 (fr) Préparation
PH12013500577A1 (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
CL2013002934A1 (es) Polimeros conjugados analogos de prostaglandinas; metodo de preparacion; implante y uso en el tratamiento del glaucoma.
WO2011116020A3 (fr) Formulations ophthalmiques de cétirizine et leurs méthodes d'utilisation
WO2011049327A3 (fr) Composition de soin externe pour la peau comprenant un sel et du sucre en tant que principes actifs pour prévenir et traiter la vaginose et utilisation de cette composition
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
WO2013046059A3 (fr) Procédés et compositions destinés au traitement d'une maladie oculaire à base de tamarin en combinaison avec le tréhalose
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
HK1231376A1 (zh) 局部制剂及其应用
WO2012097272A8 (fr) Compositions d'hydrogel stable incluant des additifs
WO2013059233A3 (fr) Compositions thermosensibles à usage dermatologique et méthodes associées
WO2014142469A3 (fr) Composition de gouttes ophtalmiques pour le traitement d'une maladie inflammatoire oculaire et son procédé de préparation
WO2014145236A3 (fr) Utilisation de sdf-1 d'atténuation de formation de cicatrice
BR112014004737A2 (pt) composto de composição de cloridrato de ambroxol e método de preparação do composto
WO2014080015A3 (fr) Compositions et procédés de croissance pileuse
WO2014116015A3 (fr) Composition pour la prévention de la maladie d'alzheimer, contenant un sel de bambou pourpre, et procédé de préparation de sel de bambou pourpre

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12835737

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12835737

Country of ref document: EP

Kind code of ref document: A2